{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:02:22Z","timestamp":1761512542936},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ygyno.2008.02.001","type":"journal-article","created":{"date-parts":[[2008,5,11]],"date-time":"2008-05-11T08:07:22Z","timestamp":1210493242000},"page":"S31-S39","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S","title":["The current and future role of screening in the era of HPV vaccination"],"prefix":"10.1016","volume":"109","author":[{"given":"Evan","family":"Myers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2008.02.001_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer Statistics 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"10.1016\/j.ygyno.2008.02.001_bib3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJMe078155","article-title":"Molecular screening for cervical cancer\u2014time to give up Pap tests?","volume":"357","author":"Runowicz","year":"2007","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3322\/canjclin.51.2.92","article-title":"Cervical cancer: prevention, diagnosis, and therapeutics","volume":"51","author":"Janicek","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2008.02.001_bib5","series-title":"Cancer facts & figures 2007","author":"ACS","year":"2007"},{"key":"10.1016\/j.ygyno.2008.02.001_bib6","unstructured":"Berg A, Atkins D. Screening for cervical cancer. Recommendations and rationale. Guide to Clinical Preventive Services. 2nd Ed. US Preventive Services Task Force. Rockville, MD: Agency to Health Care Research and Quality. 2004."},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2008.02.001_bib7","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.vaccine.2006.05.113","article-title":"Chapter 7: achievements and limitations of cervical cytology screening","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2008.02.001_bib8","series-title":"Cervical cancer","author":"CRUK. Cancer Research UK","year":"2007"},{"key":"10.1016\/j.ygyno.2008.02.001_bib9","series-title":"Cervical cancer","author":"IARC. International Agency for Research on Cancer. IARC Screening Group","year":"2005"},{"key":"10.1016\/j.ygyno.2008.02.001_bib10","series-title":"The Pap test: questions and answers","author":"National Cancer Institute","year":"2007"},{"issue":"16","key":"10.1016\/j.ygyno.2008.02.001_bib11","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMp038147","article-title":"How often should we screen for cervical cancer?","volume":"349","author":"Feldman","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ygyno.2008.02.001_bib12","series-title":"How is cervical cancer staged?","author":"American Cancer SocietyDetailed Guide: Cervical Cancer","year":"2006"},{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/GRF.0b013e31804a8285","article-title":"Cervical cancer screening in the 21st century: is it time to retire the PAP smear?","volume":"50","author":"Wright","year":"2007","journal-title":"Clin Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ygyno.2008.02.001_bib14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ygyno.2008.02.001_bib15","first-page":"1017","article-title":"Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection","volume":"164","author":"Franco","year":"2001","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.ygyno.2008.02.001_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00003081-200109000-00009","article-title":"New innovations in cervical cancer screening","volume":"44","author":"Cohn","year":"2001","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1097-0339(199801)18:1<24::AID-DC5>3.0.CO;2-U","article-title":"Recent advances in thin-layer cytology","volume":"18","author":"Linder","year":"1998","journal-title":"Diagn Cytopatho"},{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib18","first-page":"139","article-title":"ThinPrep Papanicolaou testing to reduce false-negative cervical cytology","volume":"122","author":"Linder","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ygyno.2008.02.001_bib19","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ijgo.2005.01.009","article-title":"A critical assessment of screening methods for cervical neoplasia","volume":"89","author":"Sankaranarayanan","year":"2005","journal-title":"Int J Gynecol Obstet"},{"issue":"7609","key":"10.1016\/j.ygyno.2008.02.001_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijgo.2007.07.023","article-title":"A comparison of liquid-based cytology with conventional cytology","volume":"100","author":"Celik","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ygyno.2008.02.001_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1159\/000328292","article-title":"Does liquid-based technology really improve detection of cervical neoplasia? A prospective, randomized trial comparing the ThinPrep test with the conventional Pap test, including follow-up of HSIL cases","volume":"45","author":"Obwegeser","year":"2001","journal-title":"Acta Cytol"},{"issue":"9505","key":"10.1016\/j.ygyno.2008.02.001_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(06)67961-0","article-title":"Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review","volume":"367","author":"Davey","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2008.02.001_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cncr.22953","article-title":"Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program: a prospective randomized study","volume":"111","author":"Strander","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.02.001_bib26","series-title":"Liquid-based cytology and human papillomavirus testing in cervical cancer screening. Canadian Coordinating Office for Health Technology Assessment","author":"Noorani","year":"2003"},{"key":"10.1016\/j.ygyno.2008.02.001_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.AOG.0000298948.65284.d5","article-title":"Evidence-based medicine versus liquid-based cytology","volume":"111","author":"Sawaya","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ygyno.2008.02.001_bib28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevelence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2008.02.001_bib30","series-title":"Genital HPV infection\u2014CDC fact sheet. Centers for Disease Control and Prevention","author":"CDC. Centers for Disease Control and Prevention","year":"2004"},{"issue":"4","key":"10.1016\/j.ygyno.2008.02.001_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ygyno.2008.02.001_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Human papillomavirus and cervical cancer burden and assessment of causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ygyno.2006.08.053","article-title":"Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies","volume":"104","author":"Koliopoulos","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1309\/BA43HMCAJ26VWQH3","article-title":"Interlaboratory reliability of Hybrid Capture 2","volume":"122","author":"Castle","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.ygyno.2008.02.001_bib36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/JCM.40.3.1088-1090.2002","article-title":"Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible","volume":"40","author":"Castle","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ygyno.2008.02.001_bib37","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ygyno.2008.02.001_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/dc.20681","article-title":"Interlaboratory reproducibility of liquid-based equivocal cervical cytology within a randomized controlled trial framework","volume":"35","author":"Confortini","year":"2007","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cncr.22423","article-title":"The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology","volume":"111","author":"Sherman","year":"2007","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2008.02.001_bib40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/507909","article-title":"Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer","volume":"194","author":"Wheeler","year":"2006","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.ygyno.2008.02.001_bib41","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"New Engl J Med"},{"issue":"16","key":"10.1016\/j.ygyno.2008.02.001_bib42","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"NEJM"},{"key":"10.1016\/j.ygyno.2008.02.001_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cncr.11673","article-title":"Liquid-based cervical cytology","volume":"99","author":"Klinkamer","year":"2003","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.ygyno.2008.02.001_bib44","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"New Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2008.02.001_bib45","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/j.vaccine.2006.05.114","article-title":"Chapter 19: cost-effectiveness of cervical cancer screening","volume":"24","author":"Goldie","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ygyno.2008.02.001_bib46","first-page":"1","article-title":"Cervical cancer prevention: toward cost-effective screening","volume":"1","author":"McMeekin","year":"1999","journal-title":"MedGenMed"},{"key":"10.1016\/j.ygyno.2008.02.001_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/oxfordjournals.jncimonographs.a003471","article-title":"Chapter 15: public health policy and cost-effectiveness analysis","volume":"31","author":"Goldie","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1363\/3601104","article-title":"The estimated direct medical cost of sexually transmitted diseases among American youth, 2000","volume":"36","author":"Chesson","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"issue":"3","key":"10.1016\/j.ygyno.2008.02.001_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0167-6296(88)90030-6","article-title":"A QALY is a QALY\u2014or is it?","volume":"7","author":"Weinstein","year":"1988","journal-title":"J Health Econ"},{"issue":"4","key":"10.1016\/j.ygyno.2008.02.001_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/0272989X9901900404","article-title":"Theoretically correct cost-effectiveness analysis","volume":"19","author":"Weinstein","year":"1999","journal-title":"Med Decis Making"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2008.02.001_bib51","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0020-7292(07)60016-2","article-title":"A public health approach to cervical cancer control: considerations of screening and vaccination strategies","volume":"94","author":"Goldie","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"5 Pt 1","key":"10.1016\/j.ygyno.2008.02.001_bib52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0029-7844(00)00979-0","article-title":"Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening","volume":"96","author":"Myers","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"9509","key":"10.1016\/j.ygyno.2008.02.001_bib53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ygyno.2008.02.001_bib54","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMoa035419","article-title":"Risk of cervical cancer associated with extending the interval between cervical-cancer screenings","volume":"349","author":"Sawaya","year":"2003","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.ygyno.2008.02.001_bib55","first-page":"780","article-title":"New tests for cervical cancer screening","volume":"64","author":"Nuovo","year":"2001","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2008.02.001_bib57","series-title":"Healthy People 2010. 3-Cancer","author":"CDC. Centers for Disease Control. US Department of Health and Human Services","year":"2007"},{"issue":"3","key":"10.1016\/j.ygyno.2008.02.001_bib58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"International journal of cancer"},{"issue":"9580","key":"10.1016\/j.ygyno.2008.02.001_bib59","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2008.02.001_bib60","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.vaccine.2006.05.061","article-title":"Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ygyno.2008.02.001_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1473-3099(07)70083-X","article-title":"Cost-effectiveness analyses of human papillomavirus vaccination","volume":"7","author":"Newall","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ygyno.2008.02.001_bib62","series-title":"Cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"issue":"6","key":"10.1016\/j.ygyno.2008.02.001_bib63","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.290.6.781","article-title":"Potential health and economic impact of adding a human papillomavirus vaccine to screening programs","volume":"290","author":"Kulasingam","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ygyno.2008.02.001_bib64","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"48","key":"10.1016\/j.ygyno.2008.02.001_bib65","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1016\/j.vaccine.2007.09.035","article-title":"Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S","volume":"25","author":"Kulasingam","year":"2007","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.ygyno.2008.02.001_bib66","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMe078060","article-title":"HPV vaccination\u2014more answers, more questions","volume":"356","author":"Sawaya","year":"2007","journal-title":"New Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2008.02.001_bib67","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.vaccine.2006.06.014","article-title":"Chapter 13: current findings from prophylactic HPV vaccine trials","volume":"24","author":"Koutsky","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2008.02.001_bib68","unstructured":"Brown D. For the Future Study Group. HPV type 6\/11\/16\/18 vaccine: first analysis of cross-protection against persistent infection, cervical intraepithelial neoplasia, and adenocarcinoma in situ caused by oncogenic HPV types in addition to 16\/18. Presentation: G-1720b. Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Il 2007."},{"issue":"5","key":"10.1016\/j.ygyno.2008.02.001_bib69","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ygyno.2008.02.001_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib71","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ygyno.2008.02.001_bib72","series-title":"ACIP recommendations for the use of quadrivalent HPV vaccine. Morbidity and mortality weekly report","author":"CDC. CDC","year":"2006"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib73","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajog.2004.01.042","article-title":"The health care costs of cervical human papillomavirus-related disease","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2008.02.001_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","article-title":"Cost-effectiveness of a potential vaccine for human papillomavirus","volume":"9","author":"Sanders","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.ygyno.2008.02.001_bib75","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programs","volume":"10","author":"Taira","year":"2004","journal-title":"Emerg Infect Dis"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T21:23:56Z","timestamp":1546032236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0090825808000851"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.02.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}